Log In
Print
BCIQ
Print
Print this Print this
 

Dexdor, Dexmedetomidine (Precedex)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionSelective adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnesthesia
Indication DetailsLight-to-moderate sedation for mechanically ventillated patients; Long-term sedative for mechanically ventilated patients in the intensive care unit (ICU); Procedural sedation; Sedation during dental treatment; Sedative for patients in intensive care; Short-term sedative
Regulatory Designation
Partner Abbott Laboratories; Hospira Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,700.0M

$1,700.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today